Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
Superinvestors holding CERO, Q2 2026
No superinvestor reported holding CERO in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CERO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2022
0 superinvestors holding at quarter end
- Sold out
- Starboard Value
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- Starboard Value (−11.5%)
- Sold out
- Oaktree Capital
Q4 2021
2 superinvestors holding at quarter end